Afluria is an inactivated influenza vaccine indicated for active immunization against influenza disease.
FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older.
The most common local and systemic adverse reactions to Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines include pain and swelling at the injection site (also pruritus at the injection site and shivering in adults receiving Fluzone Intradermal Quadrivalent vaccine); myalgia, malaise ...
M-M-R®II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.
In clinical trials, MENVEO demonstrated noninferior head-to-head immunogenicity data compared to Menactra and has the broadest age indication for MenACWY vaccination
RECOMBIVAX HB: Three formulations to help protect against hepatitis B
Find information about PNEUMOVAX®23 (Pneumococcal Vaccine Polyvalent), or PPSV23, for health care professionals.
Learn about the risks and benefits of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) for both children and adults.
HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV).
Introducing FLUAD™, a next-generation flu shot for the 65+ generation. Because people 65 and older can have weakened immune systems, they could benefit from a flu vaccine created especially for their generation.1,2 FLUAD was shown in clinical trials to provide a strong immune response and have an acceptable ...
View Product Information For FLULAVAL QUADRIVALENT. See More Info Here.
Information for HCPs about FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) for flu protection in a nasal spray.
Menactra is the first meningitis vaccine approved for primary and booster vaccination in adolescents. Find more information and resources for your practice.
PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers.
PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. ... PedvaxHIB may be interchanged with other licensed Haemophilus b conjugate vaccines for the booster dose.
Learn about the risks & benefits of Trumenba® (Meningococcal Group B Vaccine), a serogroup B meningococcal disease vaccine that may help protect adolescent and young adult patients, age 10 through 25 years.
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older. ... Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Health care professionals can access resources and find information about ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) at merckvaccines.com
The Threat Of Influenza Is Formidable But Now So Are Your Vaccine Options
Twinrix Adult is indicated for use in adults and adolescents (16 years of age and above) and Twinrix Paediatric is indicated for children and adolescents
Find information about ZOSTAVAX® (Zoster Vaccine Live) for Health Care Professionals including Prescribing Information and Patient Information.
Find information about VAQTA (Hepatitis A Vaccine, Inactivated) for health care professionals.
VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b. VAXELIS is approved for use as a 3-dose series in children from 6 weeks through 4 years of age (prior to the 5th birthday).
The only rotavirus vaccine. ... The first dose of RotaTeq should be administered between 6 and 12 weeks of age. ... Before administering RotaTeq® (Rotavirus Vaccine, Live, Oral, Pentavalent), please read the Prescribing Information.
Adults older than 65 years of age: Primary immunization with IXIARO consists of two (2) 0.5 mL doses, administered 28 days apart. Complete the primary immunization series at least 1 week prior to potential exposure to JEV.
HIBERIX is a primary series and booster Hib vaccine to help protect against Haemophilus influenzae type b.